FDA Approvals: Humira and Angeliq

The FDA has approved new and expanded indications for adalimumab subcutaneous injection (Humira), and drospirenone plus estradiol 0.5- and 1.0-mg tablets (Angeliq).Yael Waknine

Continue to FDA Approvals: Humira and Angeliq on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz